• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Xeljanz (tofacitinib citrate) - Articles and news items

Positive top-line results for tofacitinib citrate in active psoriatic arthritis

Industry news / 8 June 2016 / Victoria White, Digital Content Producer

The OPAL Beyond study met its primary efficacy endpoints demonstrating a statistically significant improvement with tofacitinib 5 mg BID and 10 mg BID…


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +